文献速递产科

循证剖宫产:术后管理(第10部分)

Evidence-based cesarean delivery: postoperative care (part 10).
PubMed 文献 · Am J Obstet Gynecol MFM · 2024-11-16

本综述聚焦剖宫产术后常规管理,涵盖加速康复外科具体建议及产后咨询要点。文中汇总了预防性抗生素使用指征、镇痛方案、血栓预防、导尿管拔除、饮食恢复、恶心呕吐预防、早期活动、敷料管理及出院时机等推荐,并指出实施循证术后管理方案可缩短住院时间、降低手术部位感染率、提高患者满意度和母乳喂养率。

要点

  • 剖宫产术后不推荐所有患者预防性多剂抗生素,仅肥胖未用阿奇霉素、手术≥4小时、出血>1500 mL或羊膜腔感染时追加。
  • 多模式镇痛推荐定时对乙酰氨基酚口服650 mg每6小时,非甾体抗炎药如酮咯酸30 mg静脉每6小时共4次后布洛芬600 mg口服每6小时,短效阿片类仅用于爆发痛。
  • 低危患者机械性血栓预防至下床活动,化学预防仅用于有额外危险因素者;术中留置导尿管术后立即拔除。

核心结论

  • 实施循证剖宫产术后管理方案可缩短住院时间、降低手术部位感染率、提高患者满意度和母乳喂养率。

研究设计与样本

  • 本文为综述,聚焦剖宫产术后常规管理,包括加速康复外科具体建议及产后咨询要点。

主要发现

  • 剖宫产术后预防性多剂抗生素证据不足;肥胖未术前用阿奇霉素、手术≥4小时、出血>1500 mL或羊膜腔感染时应追加抗生素。
  • 预防产后出血应继续缩宫素输注;术后多模式镇痛推荐定时对乙酰氨基酚口服650 mg每6小时和非甾体抗炎药(酮咯酸30 mg静脉每6小时共4次后布洛芬600 mg口服每6小时),短效阿片类仅用于爆发痛。
  • 低危患者机械性血栓预防至下床活动,化学预防仅用于有额外危险因素者;术中留置导尿管术后立即拔除。
  • 咀嚼口香糖助肠功能恢复,术后2小时内可早期经口进食固体食物;预防恶心呕吐推荐5HT3拮抗剂联合多巴胺拮抗剂或皮质激素(基于非剖宫产数据)。
  • 术后4小时开始早期活动并以计步器激励;皮肤切口敷料有限证据支持留置48小时;低危患者若可行1-2天新生儿门诊随访,最早24-28小时出院,否则48-72小时出院。

关键数值与推荐

  • 术后追加抗生素指征:肥胖未术前用阿奇霉素、剖宫产自预防剂量起≥4小时、出血>1500 mL或羊膜腔感染。
  • 镇痛:对乙酰氨基酚口服650 mg每6小时;酮咯酸30 mg静脉每6小时共4次后布洛芬600 mg口服每6小时;短效阿片类仅用于爆发痛。
  • 预防恶心呕吐:5HT3拮抗剂联合多巴胺拮抗剂或皮质激素(基于非剖宫产数据)。
  • 低危患者机械性血栓预防至下床活动;化学预防仅用于有额外危险因素者。
  • 出院时机:低危患者若可行1-2天新生儿门诊随访,最早24-28小时出院,否则48-72小时出院。

临床怎么用

  • 术后继续多模式镇痛,出院时继续对乙酰氨基酚和布洛芬;如需短效阿片类,根据住院期间阿片需求量个体化处方。
  • 住院期间产后咨询包括最佳妊娠间隔18-23个月、鼓励纯母乳喂养至少6个月、尽快恢复体力活动及耐受后恢复阴道性交。
  • 剖宫产术前应告知产后立即放置宫内节育器、术中输卵管切除术或产后放置长效可逆避孕措施的选择。

局限性

  • 预防恶心呕吐的推荐基于非剖宫产数据。
  • 皮肤切口敷料留置48小时的证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The following review focuses on routine postoperative care after cesarean delivery (CD), including specific Enhanced Recovery After Cesarean recommendations as well as important postpartum counseling points. Following CD, there is insufficient evidence to support administration of prophylactic multi-dose antibiotics to all patients. Additional antibiotic doses are indicated for the following scenarios: patients with obesity who did not receive preoperative azithromycin, CD lasting ≥4 hours since prophylactic dose, blood loss >1500 mL, or those with an intra-amniotic infection. An oxytocin infusion for prevention of postpartum hemorrhage should be continued post-CD. While initial measures to prevent postoperative pain occur in the intraoperative period, with the consideration of 1 g intravenous (IV) acetaminophen and IV or intramuscular nonsteroidal anti-inflammatory medications (eg, 30 mg IV ketorolac), the focus postoperatively continues with this multimodal approach with scheduled acetaminophen per os (PO, 650 mg every 6 hours) and nonsteroidal agents (ketorolac 30 mg IV every 6 hours for 4 doses followed by ibuprofen 600 mg PO every 6 hours) being recommended. Short-acting opioids should be reserved for breakthrough pain. Low-risk patients should receive mechanical thromboprophylaxis until ambulation with chemoprophylaxis being reserved for patients with additional risk factors. When an indwelling bladder catheter was placed intraoperatively for scheduled CD, it should be removed immediately postoperatively. Chewing gum to aid in return of bowel function and early oral intake of solid food can occur immediately after CD and within 2 hours, respectively. For prevention of postoperative nausea and vomiting, administration of 5HT3 antagonists with the addition of either a dopamine antagonist or a corticosteroid is recommended based on noncesarean data. Early ambulation after CD starting 4 hours postoperatively is encouraged and should be incentivized by pedometer. For patients that receive a dressing over the CD skin incision, limited evidence supports leaving it in place for 48 hours. Adjunct nonpharmacologic interventions for postoperative recovery discussed in this review are acupressure, acupuncture, aromatherapy, coffee, ginger, massage, reiki, and transcutaneous electrical nerve stimulation. In the low-risk patient, hospital discharge may occur as early as 24 to 28 hours if close (ie, 1-2 days) outpatient neonatal follow-up is available due to the potential for neonatal jaundice; otherwise, patients should be discharged at 48 to 72 hours postoperatively. Upon discharge, the multimodal pain control recommendations of acetaminophen and ibuprofen should be continued. If short-acting opioids are necessary, the prescribing practices should be individualized based upon the inpatient opioid requirements. Other portions of postoperative/postpartum counseling during the inpatient stay include the optimal interpregnancy interval of 18 to 23 months, encouraging exclusive breastfeeding for at least 6 months, quick resumption of physical activity, and vaginal intercourse guidance as tolerated. Patients should also be counseled pre-CD on the option of immediate postpartum intrauterine devices insertion, intraoperative salpingectomy, or placement of long-acting reversible contraception in the postpartum period. Implementation of such evidence-based postoperative care protocols decrease length of stay, surgical site infection rates, and improve patient satisfaction and breastfeeding rates. El resumen está disponible en Español al final del artículo.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Mackeen AD, Sullivan MV, Bender W, et al. Evidence-based cesarean delivery: postoperative care (part 10). Am J Obstet Gynecol MFM. 2024. PMID: 39557196. doi:10.1016/j.ajogmf.2024.101549

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。